Racial and ethnic disparities in alzheimer's disease pharmacotherapy exposure: an analysis across four state medicaid populations

American Journal of Geriatric Pharmacotherapy

Volumn 10, Issue 5, 2012, Pages 303-312

  Gilligan, Adrienne M ^a   Malone, Daniel C ^a   Warholak, Terri L ^a   Armstrong, Edward P ^a  

^a Division of Plant Pathology and Microbiology   (United States)

Author keywords

Alzheimer's disease; health disparities; Medicaid; pharmacotherapy

Indexed keywords

CHOLINESTERASE INHIBITOR; MEMANTINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DRUG EXPOSURE; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HUMAN; ICD-9; MAJOR CLINICAL STUDY; MALE; MEDICAID; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LOGISTIC MODELS; MALE; MEDICAID; MEMANTINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES;

EID: 84867372447     PISSN: 15435946     EISSN: 18767761     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2012.09.002     Document Type: Article

References (53)

1. Alzheimer's Association 2009 Alzheimer's disease facts and figures Alzheimers Dement 5 2009 234 270
2. G.M. Levin, T.M. Bowles, M.J. Ehret Alzheimer's disease 2nd ed. M.A. Chisholm-Burns, B.G. Wells, Pharmacother Principles Pract 1 2007 McGraw-Hill New York, NY 513 523
3. A. Areosa Sastre, R. McShane, F. Sherriff Memantine for dementia Cochrane Database Syst Rev 4 2004 CD003154
4. J. Birks, J. Grimley Evans, V. Iakovidou Rivastigmine for Alzheimer's disease Cochrane Database Syst Rev 2 2009 CD001191
5. J.S. Birks, R. Harvey Donepezil for dementia due to Alzheimer's disease Cochrane Database Syst Rev 3 2003 CD001190
6. N. Qizilbash, A. Whitehead, J. Higgins Cholinesterase inhibition for Alzheimer disease: s meta-analysis of the tacrine trials Dementia trialists' collaboration JAMA 280 1998 1777 1782
7. C. Loy, L. Schneider Galantamine for Alzheimer's disease Cochrane Database Syst Rev 4 2004 CD001747
8. K.M. Mehta, M. Yin, C. Resendez Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer's disease Neurology 65 2005 159 162
9. A.J. Lerner, M.J. McClendon, S.A. Sami Factors affecting usage patterns of memantine in Alzheimer's disease Alzheimer Dis Assoc Disord 22 2008 137 143
10. D.J. Gaskin, B.A. Briesacher, R. Limcangco Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries Am J Geriatr Pharmacother 4 2006 96 111
11. I.H. Zuckerman, P.T. Ryder, L. Simoni-Wastila Racial and ethnic differences in the treatment of dementia among Medicare beneficiaries J Gerontol B Psychol Sci Soc Sci 63 2008 328 333
12. I. Poon, L.S. Lal, M.E. Ford Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study Ann Pharmacother 43 2009 185 193
13. L. Boise, D.L. Morgan, J. Kaye Delays in the diagnosis of dementia: Perspectives of family caregivers Am J Alzheimers Dis Other Dement 14 1999 20 26
14. L. Boise, R. Camicioli, D.L. Morgan Diagnosing dementia: perspectives of primary care physicians Gerontologist 39 1999 457 464
15. C.M. Connell, M.P. Gallant Spouse caregivers' attitudes toward obtaining a diagnosis of a dementing illness J Am Geriatr Soc 44 1996 1003 1009
16. C.M. Connell, B.A. Shaw, S.B. Holmes Caregivers' attitudes toward their family members' participation in Alzheimer disease research: Implications for recruitment and retention Alzheimer Dis Assoc Disord 15 2001 137 145
17. C.M. Connell, L. Boise, J.C. Stuckey Attitudes toward the diagnosis and disclosure of dementia among family caregivers and primary care physicians Gerontologist 44 2004 500 507
18. R.H. Fortinsky Health care triads and dementia care: Integrative framework and future directions Aging Ment Health 5 2001 35 48
19. J.S. Roberts, C.M. Connell Illness representations among first-degree relatives of people with Alzheimer's disease Alzheimer Dis Assoc Disord 14 2000 129 136
20. C.M. Connell, S.J. Roberts, S.J. McLaughlin Racial differences in knowledge and beliefs about Alzheimer's disease Alzheimer Dis Assoc Disord 23 2009 110 116
21. S. Hernandez, M.J. McClendon, X.H. Zhou Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables J Alzheimers Dis 19 2010 665 672
22. M.E. Charlson, P. Pompei, K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
23. R. Oaxaca Male-female wage differentials in urban labor markets Int Econ Rev 14 1973 693 709
24. A.S. Blinder Wage discrimination: reduced form and structural estimates J Hum Res 8 1973 436 455
25. R.W. Fairlie An extension of the Blinder-Oaxaca decomposition technique to logit and probit models J Econ Soc Manag 30 2005 305
26. L. Shi, L.A. Lebrun, J. Tsai Access to medical care, dental care, and prescription drugs: the roles of race/ethnicity, health insurance, and income South Med J 103 2010 509 516
27. T.A. LaVesit, K.J. Nickerson, J.V. Bowie Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients Med Care Res Rev 57 2000 146 161
28. N. Lurie, C. Zhan, J. Sangl Variation in racial and ethnic differences in consumer assessments of health care Am J Manag Care 9 2003 502 509
29. M. van Ryn, J. Burke The effect of patient race and socio-economic status on physicians' perceptions of patients Soc Sci Med 50 2000 813 828
30. D. Williams Race, socioeconomic status, and health: the added effects of racism and discrimination Ann N Y Acad Sci 896 1999 173 188
31. D.L. Bachman, P.A. Wolf, R.T. Linn Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study Neurology 43 1993 515 519
32. L. Fratiglioni, M. Viitanen, E. von Strauss Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen project, Stockholm Neurology 48 1997 132 138
33. M. Ganguli, H.H. Dodge, C. Shen Alzheimer disease and mortality: a 15-year epidemiological study Arch Neurol 62 2005 779 784
34. M.R. Farlow, D.K. Lahiri, J. Poirier Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease Neurology 50 1998 669 677
35. K.M. Beusterien, S.K. Thomas, D. Gause Impact of rivastigmine use on the risk of nursing home placement in a US sample CNS Drugs 18 2004 1143 1148
36. O.L. Lopez, J.T. Becker, S. Wisniewski Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease J Neurol Neurosurgy Psychiatry 72 2002 310 314
37. D. Knopman, L. Schneider, K. Davis Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality, Tacrine Study Group Neurology 47 1996 166 177
38. T.L. Hopper "They're just going to get worse anyway:" perspectives on rehabilitation for nursing home residents with dementia J Commun Disord 36 2003 345 359
39. J.A. Mauskopf, C. Paramore, W.C. Lee Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings J Manag Care Pharm 11 2005 231 251
40. N. Herrmann, C. Binder, W. Dalziel Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study Drugs Aging 26 2009 403 407
41. D.C. Suh, S.K. Thomas, E. Valiyeva Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease Drugs Aging 22 2005 695 707
42. B.D. Smedley, A.Y. Stith, A.R. Nelson Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care 2003 National Academies Press Washington, DC
43. L.R. Snowden Barriers to effective mental health services for African Americans Ment Health Serv Res 3 2001 181 187
44. C. Shen, M. Smyer, K.J. Mahoney Consumer-directed care for beneficiaries with mental illness: lessons from New Jersey's Cash and Counseling Program Psychiatr Serv 59 2008 1299 1306
45. L. Foster, R. Brown, B. Phillips Easing the burden of caregiving: the impact of consumer direction on primary informal caregivers in Arkansas Gerontologist 45 2005 474 485
46. K.J. Mahoney, L. Simon-Rusinowitz, K. Simone Cash and counseling: a promising option for consumer-direction of home and community-based services and supports Care Manag J 7 2006 199 204
47. L. Foster, R. Brown, B. Phillips Improving Quality of Medicaid Personal Assistance Through Consumer Direction 2003 Mathematica Policy Research Princeton, NJ
48. B.L. Carlson, L. Foster, S. Dale Effect of cash and counseling on personal care and well-being Health Serv Res 42 2007 467 487
49. Fiscal Forecasting and Data Management Branch Medi-Cal Local Assistance Estimate for Fiscal Years 2006-2007 and 2007-2008: Assumptions 2007 California Department of Health Services Sacramento, Calif
50. A.E. Headen Jr, N.A. Masia, K.J. Axelsen Effects of Medicaid access restrictions on statin utilization for patients treated by physicians practicing in poor and minority neighborhoods Pharmacoeconomics 24 2006 41 53
51. G.F. Kominski, D.E. Morisky, A.A. Afifi The effect of disease management on utilization of services by race/ethnicity: evidence from the Florida Medicaid program Am J Manag Care 14 2008 168 172
52. P.J. Cunningham State variation in primary care physician supply: implications for health reform Medicaid expansions Health System Change Research Brief No. 19 March 2011
53. S. Crystal, A. Akincigil, S. Bilder Studying prescription drug use and outcomes with Medicaid claims data: strengths, limitations, and strategies Med Care 45 2007 58 65